When Treating Cancer Patients, Perseverance Is Key
Advertisement
In an interview with Pharmacy Times at the National Community Oncology Dispensing Association (NCODA) 2017 Fall Summit, Michael Broderson, PharmD, discussed the importance of perseverance when managing therapies and interacting with oncology patients.
A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
In an interview with Pharmacy Times, Thomas Hope, MD, explains how earlier consideration of peptide receptor radionuclide therapy in neuroendocrine tumors makes treatment scheduling and continuity of care essential opportunities for pharmacists.
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.